Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathella Pavan Kumar

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
BMC Bioinformatics|November 1, 2025
Delineating markers of disease-disease interaction: a systematic methodology and its application to multiple diabetes-helminth cohortsNilesh Subramanian, Philge Philip, Anuradha Rajamanickam, et al.
European Journal of Immunology|November 1, 2015
Coincident diabetes mellitus modulates Th1-, Th2-, and Th17-cell responses in latent tuberculosis in an IL-10- and TGF-β-dependent mannerNathella Pavan Kumar, Kadar Moideen, Parakkal Jovvian George, et al.
The Journal of Infection|May 20, 2018
Malnutrition is associated with diminished baseline and mycobacterial antigen - stimulated chemokine responses in latent tuberculosis infectionRajamanickam Anuradha, Saravanan Munisankar, Yukthi Bhootra, et al.
Tuberculosis (Edinburgh, Scotland)|March 11, 2018
Modulation of iron status biomarkers in tuberculosis-diabetes co-morbidityNathella Pavan Kumar, Vaithilingam V Banurekha, Dina Nair, et al.
Plos One|May 30, 2020
Altered systemic levels of acute phase proteins in tuberculous lymphadenitis and modulation after treatmentGokul Raj Kathamuthu, Kadar Moideen, Nathella Pavan Kumar, et al.
Infection and Immunity|April 11, 2018
Heightened Systemic Levels of Neutrophil and Eosinophil Granular Proteins in Pulmonary Tuberculosis and Reversal following TreatmentKadar Moideen, Nathella Pavan Kumar, Dina Nair, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|May 17, 2021
Effect of anti-tuberculosis treatment on the systemic levels of tissue inhibitors of metalloproteinases in tuberculosis - Diabetes co-morbidityNathella Pavan Kumar, Kadar Moideen, Vijay Viswanathan, et al.
Pathogens (Basel, Switzerland)|January 21, 2022
Multi-Dimensionality Immunophenotyping Analyses of MAIT Cells Expressing Th1/Th17 Cytokines and Cytotoxic Markers in Latent Tuberculosis Diabetes ComorbidityGokul Raj Kathamuthu, Nathella Pavan Kumar, Kadar Moideen, et al.
The Journal of Infectious Diseases|October 22, 2015
Impaired Cytokine but Enhanced Cytotoxic Marker Expression in Mycobacterium tuberculosis-Induced CD8+ T Cells in Individuals With Type 2 Diabetes and Latent Mycobacterium tuberculosis InfectionNathella Pavan Kumar, Kadar Moideen, Parakkal Jovvian George, et al.
Tuberculosis (Edinburgh, Scotland)|August 21, 2019
Diminished type 1 and type 17 cytokine expressing - Natural killer cell frequencies in tuberculous lymphadenitisGokul Raj Kathamuthu, Nathella Pavan Kumar, Kadar Moideen, et al.
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
BMC Bioinformatics|November 1, 2025
Delineating markers of disease-disease interaction: a systematic methodology and its application to multiple diabetes-helminth cohortsNilesh Subramanian, Philge Philip, Anuradha Rajamanickam, et al.
European Journal of Immunology|November 1, 2015
Coincident diabetes mellitus modulates Th1-, Th2-, and Th17-cell responses in latent tuberculosis in an IL-10- and TGF-β-dependent mannerNathella Pavan Kumar, Kadar Moideen, Parakkal Jovvian George, et al.
The Journal of Infection|May 20, 2018
Malnutrition is associated with diminished baseline and mycobacterial antigen - stimulated chemokine responses in latent tuberculosis infectionRajamanickam Anuradha, Saravanan Munisankar, Yukthi Bhootra, et al.
Tuberculosis (Edinburgh, Scotland)|March 11, 2018
Modulation of iron status biomarkers in tuberculosis-diabetes co-morbidityNathella Pavan Kumar, Vaithilingam V Banurekha, Dina Nair, et al.
Plos One|May 30, 2020
Altered systemic levels of acute phase proteins in tuberculous lymphadenitis and modulation after treatmentGokul Raj Kathamuthu, Kadar Moideen, Nathella Pavan Kumar, et al.
Infection and Immunity|April 11, 2018
Heightened Systemic Levels of Neutrophil and Eosinophil Granular Proteins in Pulmonary Tuberculosis and Reversal following TreatmentKadar Moideen, Nathella Pavan Kumar, Dina Nair, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|May 17, 2021
Effect of anti-tuberculosis treatment on the systemic levels of tissue inhibitors of metalloproteinases in tuberculosis - Diabetes co-morbidityNathella Pavan Kumar, Kadar Moideen, Vijay Viswanathan, et al.
Pathogens (Basel, Switzerland)|January 21, 2022
Multi-Dimensionality Immunophenotyping Analyses of MAIT Cells Expressing Th1/Th17 Cytokines and Cytotoxic Markers in Latent Tuberculosis Diabetes ComorbidityGokul Raj Kathamuthu, Nathella Pavan Kumar, Kadar Moideen, et al.
The Journal of Infectious Diseases|October 22, 2015
Impaired Cytokine but Enhanced Cytotoxic Marker Expression in Mycobacterium tuberculosis-Induced CD8+ T Cells in Individuals With Type 2 Diabetes and Latent Mycobacterium tuberculosis InfectionNathella Pavan Kumar, Kadar Moideen, Parakkal Jovvian George, et al.
Tuberculosis (Edinburgh, Scotland)|August 21, 2019
Diminished type 1 and type 17 cytokine expressing - Natural killer cell frequencies in tuberculous lymphadenitisGokul Raj Kathamuthu, Nathella Pavan Kumar, Kadar Moideen, et al.
Pageof 10